AVI BIOPHARMA, INC. – Trademark Portfolio
Entity Type: 03
AVI BIOPHARMA, INC. holds 21 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 12 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 4 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include SAREPTA and SAREPTA THERAPEUTICS. The owner is based in Bothell, WA.
3450 Monte Villa Parkway, Suite 101
Bothell, WA 98021
Showing of trademarks Trademarks
Trademark Classifications
AVI BIOPHARMA, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does AVI BIOPHARMA, INC. have?
AVI BIOPHARMA, INC. has 21 U.S. trademarks filed with the USPTO. Of these, 2 registered, 10 abandoned, 9 cancelled.
What trademark classes does AVI BIOPHARMA, INC. file in?
AVI BIOPHARMA, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are AVI BIOPHARMA, INC.'s most well-known trademarks?
AVI BIOPHARMA, INC.'s registered trademark portfolio includes well-known marks such as SAREPTA and SAREPTA THERAPEUTICS. These are among 2 currently registered trademarks in the portfolio.
What is AVI BIOPHARMA, INC.'s trademark registration success rate?
AVI BIOPHARMA, INC. has a 10% trademark registration rate, with 2 out of 21 resolved applications resulting in successful registration. Currently, 0 applications are pending review.